Brookfield Asset Management Inc. Axonics, Inc. Transaction History

Brookfield Asset Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $1.41 Million - $1.9 Million	-24,258 Reduced 62.79%	14,373 $1.01 Million
Q2 2022 Nov 16, 2022	BUY	$39.5 - $64.42 $958,191 - $1.56 Million	24,258 Added 168.77%	38,631 $2.19 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $1.53 Million - $2.49 Million	38,631 New	38,631 $2.19 Million

10.1M

5.2K

58.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.